Search Results

Metabolic Syndrome and Adipokines Profile in Bipolar Depression.

• Authors : Bilska, Karolina¹; Dmitrzak-Węglarz, Monika¹ ; Osip, Przemysław²

Subjects: *METABOLIC syndrome risk factors; *ADIPOKINES; *BIOMARKERS

• Source: Nutrients. Nov2023, Vol. 15 Issue 21, p4532. 13p.

Record details

Pediatric drug research and mental illness.

• Authors : Sallee FR

Subjects: Research*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Mental Disorders/Mental Disorders/Mental Disorders/*drug therapy

• Source: FDA consumer [FDA Consum] 2003 Jan-Feb; Vol. 37 (1), pp. 40.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

Record details

A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics.

• Authors : Fukuyama, Kouji¹; Motomura, Eishi¹; Okada, Motohiro¹

Subjects: *BIOCHEMISTRY; *AMINOBUTYRIC acid; *BIOLOGICAL models

• Source: Nutrients. Apr2023, Vol. 15 Issue 7, p1621. 20p.

Record details

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis.

• Authors : Feber, Lena¹ (AUTHOR) ; Peter, Natalie¹ (AUTHOR); Schneider-Thoma, Johannes¹ (AUTHOR)

• Source: Systematic Reviews. 3/24/2023, Vol. 12 Issue 1, p1-8. 8p.

Record details

Stuttering treatment research 1970-2005: II. Systematic review incorporating trial quality assessment of pharmacological approaches.

• Authors : Bothe AK; Department of Communication Sciences and Special Education, The University of Georgia, Athens, GA 30602, USA. ; Davidow JH

Subjects: Research*; Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*standards ; Stuttering/Stuttering/Stuttering/*drug therapy

• Source: American journal of speech-language pathology [Am J Speech Lang Pathol] 2006 Nov; Vol. 15 (4), pp. 342-52.Publisher: American Speech-Language-Hearing Association Country of Publication: United States NLM ID: 9114726 Publication Model: Print Cited Medium:

Record details

Prizes, publications, and promotion.

• Authors : Horton R

Subjects: Drug Industry*; Publishing/Publishing/Publishing/*standards ; Research/Research/Research/*standards

• Source: Lancet (London, England) [Lancet] 1996 Nov 23; Vol. 348 (9039), pp. 1398.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print ISSN: 0140-6736 (Print)

Record details

Redundancy, disaggregation, and the integrity of medical research.

• Authors : Huston P; Department of Family Medicine, University of Ottawa, Ontario, Canada.; Moher D

Subjects: Clinical Trials as Topic* ; Duplicate Publications as Topic* ; Publishing*

• Source: Lancet (London, England) [Lancet] 1996 Apr 13; Vol. 347 (9007), pp. 1024-6.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print ISSN: 0140-6736 (Print)

Record details

Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs.

• Authors : Truong, Trang T. T.¹ (AUTHOR) ; Bortolasci, Chiara C.¹ (AUTHOR) ; Kidnapillai, Srisaiyini¹ (AUTHOR)

Subjects: *AMISULPRIDE; *ANTIPSYCHOTIC agents; *ARIPIPRAZOLE

• Source: International Journal of Molecular Sciences. Jul2022, Vol. 23 Issue 14, p7508-7508. 11p.

Record details

Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial.

• Authors : Wang, Congjie¹ ; Shi, Wenjie¹; Xu, Jianyang²

• Source: Annals of General Psychiatry. 12/10/2020, Vol. 19 Issue 1, p1-10. 10p.

Record details

The association between medication use and gait in adults with intellectual disabilities.

• Authors : Maas, S.¹; Festen, D. A. M.¹; Hilgenkamp, T. I. M.^1,2

• Source: Journal of Intellectual Disability Research. Oct2020, Vol. 64 Issue 10, p793-803. 11p. 3 Charts.

Record details